Health Care & Life Sciences » Pharmaceuticals | Ortin Laboratories Ltd.

Ortin Laboratories Ltd. | Income Statement

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
669,974.10
602,953.10
395,423.30
615,961.00
771,125.00
Cost of Goods Sold (COGS) incl. D&A
605,464.90
539,229.70
566,522.40
558,573.00
625,998.00
Gross Income
64,509.30
63,723.40
171,099.10
57,388.00
145,127.00
SG&A Expense
18,261.70
14,679.70
17,362.30
18,382.70
143,085.00
EBIT
45,855.80
48,592.80
189,329.20
37,945.60
2,042.00
Unusual Expense
2,173.70
2,203.50
5.00
35.70
-
Non Operating Income/Expense
4,430.50
712.70
235,276.30
268.70
39,627.00
Interest Expense
36,892.50
35,007.80
33,198.70
29,129.40
34,866.00
Pretax Income
16,828.00
13,333.10
13,958.90
10,204.30
6,804.00
Income Tax
4,963.70
4,353.90
5,620.40
6,273.10
11.00
Consolidated Net Income
11,864.20
8,979.20
8,338.50
3,931.20
6,792.00
Net Income
11,864.20
8,979.20
8,338.50
3,931.20
6,792.00
Net Income After Extraordinaries
11,864.20
8,979.20
8,338.50
3,931.20
6,792.00
Net Income Available to Common
11,864.20
8,979.20
8,338.50
3,931.20
6,792.00
EPS (Basic)
0.70
0.53
0.49
0.23
0.40
Basic Shares Outstanding
16,940.40
16,940.40
16,940.40
16,940.40
-
EPS (Diluted)
0.70
0.53
0.49
0.23
-
Diluted Shares Outstanding
16,940.40
16,940.40
16,940.40
16,940.40
-
EBITDA
60,906.00
65,008.10
172,854.90
54,982.50
18,897.00
Other Operating Expense
391.80
450.90
867.70
1,059.70
-
Non-Operating Interest Income
1,260.60
1,238.90
1,205.60
1,083.70
-

About Ortin Laboratories

View Profile
Address
D.No.1-2-593/29, Gagan Mahal Colony
Hyderabad TS 500029
India
Employees -
Website http://www.ortinlabsindia.com
Updated 09/14/2018
Ortin Laboratories Ltd. engages in the manufacture of drug intermediates and pharmaceuticals products. It provides tablets, capsules, syrups, and dry powders. The company's products and services include formulations, API Intermediates, research & development, bio-technology and merchant Export trading.